| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Franchising > Franchising Concerns of Sales and Marketing of National and International Accounts |
|
Advice You - Franchising Concerns of Sales and Marketing of National and International Accounts
All franchisors must address issues of national account pricing and service. The renegade fran According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product chisee who does not wish to follow the pricing guidelines for the demands of the customer can i ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in fact cause the entire franchise system to lose a major national or international account. How lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. do all you know this, you ask? Well, because this became a serious issue in our company, wher here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe we had many regional accounts with nationally known companies who wished to use our services i d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro each market we expanded into. In some cases they wished us to travel to faraway markets just ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc so we could serve their entire fleet. It is for this reason that I added this clause below to easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ur franchise agreements; 4.8 National and International Accounts To the extent that Franchiso nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically enters into an agreement to provide The Company to any National or International Account which and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ has a location within the Marketing Area, Franchisor may offer Franchisee the right to service ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi such account at such location at the terms upon which Franchisor and the National or Internatio ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a al Account have agreed. In the event that there is more than one Franchisee licensed by Franchi dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod sor in the Marketing Area, Franchisor may allocate opportunities to service National or Interna cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ional Accounts between such Franchisees, as Franchisor in its sole discretion deems appropriate tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen If, for any reason, Franchisee elects not to service a National or International Account that t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel is offered to Franchisee, Franchisor may, in its sole discretion, service such account or appoi ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust t any other party to service such account. - -- --- ---- --- -- - It is recommended that all y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ranchisors who runs service companies or sell products to large government agencies, corporatio . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ns or national organizations that they get with their franchise attorney and ask them how best elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip o address this issue for their strategic marketing plan. I hope you will consider this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Art Teacher Interview Questions Customer Service Tips - 4 Steps for Turning Customer Moments Into Customer Experiences Self Employment: The Hardest Way to Make Easy Money
|